Does gonadotropin-releasing-hormone agonist therapy for prostate cancer increase the risk of fracture? Commentary

Andrew J. Armstrong, Mario Eisenberger

Research output: Contribution to journalShort surveypeer-review

Fingerprint

Dive into the research topics of 'Does gonadotropin-releasing-hormone agonist therapy for prostate cancer increase the risk of fracture? Commentary'. Together they form a unique fingerprint.